Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol., 06 March 2023
Sec. Reproduction
This article is part of the Research Topic A Year in Review: Discussions in Reproduction View all 7 articles

Effects of Ureaplasma urealyticum infection on semen quality and sperm morphology

Fu XianchunFu XianchunFang JunFang JunDai ZhijunDai ZhijunHong Mingyun*Hong Mingyun*
  • Centre for Reproductive Medicine, Affiliated Maternity and Child Health Hospital of Anhui Medical University, Anhui Province Maternity and Child Health Hospital, Hefei, Anhui, China

Introduction: Ureaplasma urealyticum (U. urealyticum) infection is primarily associated with damage to male fertility through its effects on male sperm parameters. However, its effects on sperm semiological variables remain unclear. Therefore, this study aimed to investigate whether U. urealyticum infection was associated with semen quality and sperm morphology.

Methods: From 2019 to 2021, this cross-sectional study analyzed infective pathogens and semen variables in 1064 males (22–30 years old) recruited from our reproductive center and the general public. Routine semen parameters and normal sperm morphology rate were analyzed using methods outlined by the World Health Organization. The associations between semen quality, sperm morphology, and U. urealyticum infection were studied using general linear models.

Results: The participants were categorized into three groups: (i) U. urealyticum infection (n=328), (ii) non-U. urealyticum infection (including males with urogenital tract infection symptoms but no U. urealyticum detected in their semen samples, n=377), and (iii) normal volunteers (males without symptoms of urogenital tract infection and no pathogens detected in semen samples, n=359). U. urealyticum in semen samples was observed to be associated with lower sperm concentrations (p<0.001) and a lower ratio of anterograde motile spermatozoa (p<0.001). Semen cultures positive for U. urealyticum were associated with lower normal sperm morphology (p<0.001) compared to semen cultures negative for U. urealyticum.

Conclusion: This study shows the importance of proper investigations for U. urealyticum during routine clinical examinations and diagnoses of males with infertility.

1 Introduction

Recently, increasing attention has been paid to male reproductive health. Many studies have analyzed factors influencing sperm quality, such as obesity, lifestyle, working conditions, diet culture, congenital and heredity factors, and urogenital infections (1). Ureaplasma urealyticum (U. urealyticum) is considered a common pathogen of urogenital system-related infections that affect sperm and semen quality. Inflammatory reactions and factors caused by U. urealyticum infection likely affect the surrounding environment and normal sperm function. Moreover, U. urealyticum infection is considered a common infection that contributes to changes in the internal structure of sperm cells. Studies have reported that current clinical mycoplasma infections in the urogenital system of infertile males are mainly caused by U. urealyticum (2). The association between U. urealyticum infection and male infertility has been extensively studied; however, controversies persist regarding whether U. urealyticum infection could lead to male infertility. Similarly, the association between U. urealyticum infection in the reproductive tract and semen parameters is controversial (3).

Males of childbearing age are likely to suffer from U. urealyticum infection due to their active sexual life. Usually, urogenital symptoms of U. urealyticum infection are similar to those of bacterial infections in the urinary tract. In addition to being related to a decline in some sperm parameters (4), U. urealyticum is often considered the main cause of male sperm cell distortion (5). It can integrate with the head of sperm cells and cause reduced sperm motility and individual gene mutation by working as a strong distortion agent (6). Another form of sperm distortion caused by U. urealyticum infection is sperm cell deformity (7). This deformity likely develops distortions such as a decrease in the sperm’s overall antioxidant capacity and flaws emerging in DNA repair (8). Therefore, a positive correlation between U. urealyticum infection and semen parameters suggests that U. urealyticum infection is a possible index of male infertility (9).

U. urealyticum is the main causative organism of male genital tract infections. However, other pathogens such as bacteria, Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), molds, and trichinosis might also cause genital tract infections (10) at relatively low incidence rates. Hence, a previous study fully summarized the effect of U. urealyticum infection on semen by collecting and analyzing U. urealyticum and semen parameters in male patients with infertility (11) compared with data from normal patients.

Previous studies have reported that U. urealyticum infection is associated with normal sperm morphology rate (12), while others have not observed any relationship between the two (11). In addition, the outcome seems discordant with the genre of U. urealyticum infection for which such an association was discovered (13). Moreover, evidence shows that U. urealyticum infection likely results in DNA chain fractures of human semen cells. However, no association was detected between U. urealyticum infection and the sperm fragmentation index (DFI) evaluated by sperm chromatin structure assay (SCSA) (13).

Therefore, due to the controversies in current research, we aimed to study the incidence and impact of male genital U. urealyticum infection in homogeneous males with infertility.

2 Materials and methods

2.1 Study design and participants

Data for this study were collected from a randomized controlled trial that investigated the association of U. urealyticum, compared with semen parameters, as a pathogen in urogenital tract infection.

This study adopted the definition of male infertility by the World Health Organization (WHO, 5th edition), which is the inability of a male to fertilize his partner after >12 months of cohabitation with normal sexual intercourse and no contraceptive measures (10). Based on this definition, this study included 705 males aged 20–30 years with infertility who visited the reproductive center of Anhui Province Maternal and Child Health Hospital (Hefei, China) from January 2019 to May 2021. The study also included 359 young males aged 22–30 years from the general public who were permanent residents in Hefei, China. Males from the general public were recruited by (i) routine physical examinations before pregnancy (n=213) and (ii) publicity on campus (n=146). All 1064 recruited males signed the informed consent form, completed questionnaires about whether they had urogenital infection symptoms, collected and sent semen samples the same morning, and were paid 500 RMB as a reward for participation. The recruited males (i) had been residents in Hefei City for >5 years and were of Han ethnicity; males conforming to these criteria were asked to participate in the program. Data collection and investigation on U. urealyticum infection and male fertility were approved by the ethics Review Committee of Anhui Province Maternal and Child Health Hospital. Furthermore, this study was conducted in accordance with the Declaration of Helsinki.

Data collected from the 1064 males were as follows (1): duration of the abstinence period before semen sample delivery (2), semen routine parameters and normal sperm morphology rate, and (3) pathogens in the semen. Based on the results of laboratory cultures, the participants were divided into three groups: (i) U. urealyticum infection, including males with U. urealyticum detected in their semen samples, n=328), (ii) non-U. urealyticum infection, including males with urogenital tract infection symptoms but no U. urealyticum detected in their semen samples, n=377), and (iii) normal volunteers, including males with no urogenital tract infection symptoms and no pathogens detected in their semen samples, n=359).

2.2 Sample collection

Samples of human semen were collected by masturbation during an abstinence period, which was standardized to be 3–5 days in line with the WHO 2010 guidelines (14). The exact duration of the abstinence period was recorded. All males were instructed about semen and genital specimen collection, according to the national standard of reproductive laboratories, before masturbating to minimize microbial contamination during semen extraction (15). Each semen sample was poured into a sterile glass cup and liquefied in specific incubators at 37°C. When the semen sample was entirely liquefied, a volume ≥2.0 ml was required for this study. Each semen sample was used for three purposes: (i) routine semen analysis, (ii) analyzing the ratio of normal sperm morphology, and (iii) for pathogen testing.

2.3 Routine semen analysis

Routine semen analysis was performed according to the WHO Laboratory Manual for the Examination and Processing of Human Semen (5th edition) (16). Semen volume, sperm concentration, and percentage of forward movement (PR%) were analyzed using an automatic semen quality computer-aided analysis system (Spanish SCA SCOPE Company). The image acquisition module and frame image were implemented using the following parameters: most sperm concentrations were collected at 20 Hz, while higher concentrations were collected at 7 Hz; collection intermission, 3 ms; maximum velocity of sperm motility, 200 um/s; sperm motility index, and straight-line velocity. The grayscale threshold values were formulated to determine the spermatozoa and eliminate non-sperm components. Then, sperm parameters were analyzed and compared per the thresholds formulated for the semen assay.

Semen volume (mL), viscosity, liquefaction degree, and appearance were measured manually according to standard operating procedure (SOP) specifications, and the pH was tested using a litmus test paper. Next, 10 µL of each semen sample was drawn using a sampling gun on a sperm counting plate (Israel Self Medical Instruments Company). The sperm concentration (×106/ml) was obtained using an automatic semen quality computer-aided analysis system (Beijing Zhongke Hengye Co., Ltd.). Other data collected were the rates of forward sperm (%), non-forward sperm (%), inactive sperm (%), survival rate (%), average path velocity (um/s), linear motility (%), wobble (%), linear (%), and straightness (%), as well as curve velocity (um/s), the amplitude of lateral head display (um), beat cross frequency (Hz), mean angular displacement, and straight-line velocity (um/s).

Sperm smear samples were stained using the new Pasteur staining method. The percentages of normal sperm, head defects, middle and main segment defects, excessive residual cytoplasm, and round cells were observed under an oil microscope. The operation was strictly performed following the SOP.

2.3.1 Ratio of sperm normal morphology assessment

Semen smears were dyed using a Diff-Quick reagent (MICROPTIC S.L. Co., Barcelona, Spain) to analyze the ratio of normal sperm morphology (14). Briefly, 10 µL of semen sample was diffused onto a glass slide and then air-dried at an indoor temperature for more than 10 min. The smeared glass slide was stained and analyzed using a high-power microscope (BX53M; Olympus, Qingdao, China) magnified 1000 times. In line with the 2010 WHO guidelines, a spermatozoon with a malformed head, middle, and tail parts was recorded as teratozoospermia. The sperm deformity index (SDI) was calculated as the ratio of deformed sperm cells to the total number of sperm cells (17). For each sperm sample, an outnumber of 200 spermatozoa (or the entire spermatozoa if the glass slide held <200 sperm cells) was calculated using a double-blind approach. Additionally, the ratio of spermatozoa with deformities or normal morphology was calculated.

2.4 Detection of pathogenic microorganisms

All semen samples from the study population were evaluated for U. urealyticum. U. urealyticum was detected using polymerase chain reaction (PCR) with specific kits (Daan Gene Co. Ltd., Guangzhou, China). A standard curve was formulated for each test based on the kit contents. Concentrations of U. urealyticum DNA ≥500 copies/ml were considered positive (18). U. urealyticum was analyzed under high-quality control in the professional reproductive laboratory of Anhui Province Maternal and Child Health Hospital, approved by the China Food and Drug Administration (19).

2.5 Statistical analysis

Patients’ age, semen volume, pH value, liquefaction time, sperm concentration, forward moving sperm, non-forward moving sperm, viability, average path velocity, curve velocity, the amplitude of lateral head display, beat cross frequency, mean angular displacement, straight-line velocity, wobble, linear, straightness, as well as the rates of normal morphology, head deformity, and middle and main segment deformity, and round cell number, were measured and distributed normally, expressed as mean ± standard deviation (x ± s). One-way ANOVA was used to compare the differences between groups. Viscosity was a classified variable, and non-parametric tests were used for statistical analyses. Post-hoc comparisons were analyzed using Tukey’s test, where the result manifested a significant main effect, and the percent relative effects and 95% confidence intervals (CIs) were calculated. Statistically significant differences were considered at p-values <0.05, and SPSS 20.0 was used for all statistical analyses.

3 Results

3.1 Grouping of the study population

Table 1 shows normal standards for male semen parameters, such as semen volume, sperm density, percentage of sperm forward movement, the normal sperm morphology rate, pH, and sperm activation and survival rates. According to the results of microbial culture tests, Table 2 shows that the semen samples of 328 (30.83%) males had microbial cultures positive for U. urealyticum. Approximately 377 (35.43%) males were considered to have symptoms of urogenital infections based on their responses to the questionnaires; however, U. urealyticum was not detected in their semen samples. In contrast, 359 (33.74%) males were observed to have no urogenital infection symptoms, and U. urealyticum was not detected in their semen samples.

TABLE 1
www.frontiersin.org

Table 1 Normal standards on male semen quality parameters.

TABLE 2
www.frontiersin.org

Table 2 Male genital tract pathogen infection.

3.2 U urealyticum infection and semen routing parameters

Semen pH and liquefaction time were significantly higher in the U. urealyticum infection group than in the non-U. urealyticum infection and normal volunteers groups (7.28 ± 0.02 vs. 7.15 ± 0.03 vs. 7.22 ± 0.03; p=0.003 and 31.87 ± 1.41 vs. 30.72 ± 1.32 vs. 30.81 ± 1.40; p<0.001, respectively) (Table 3). In contrast, the sperm density and ratio of anterograde motile spermatozoa decreased significantly (67.52 ± 33.15 vs. 84.22 ± 41.85 vs. 73.88 ± 25.09; p<0.001 and 36.48 ± 12.70 vs. 38.97 ± 6.82 vs. 43.31 ± 8.78; p<0.001, respectively) (Table 3).

TABLE 3
www.frontiersin.org

Table 3 Correlation between male genital tract pathogen detection and routine semen quality indicators (mean ± standard deviation).

3.3 U urealyticum infection and sperm morphology

U. urealyticum infection was significantly associated with lower ratios of sperm with normal morphology (7.39 ± 3.23 vs. 10.11 ± 3.61 vs. 7.98 ± 4.51; p<0.001), compared with semen males without U. urealyticum infection (Table 4).

TABLE 4
www.frontiersin.org

Table 4 Correlation between male genital tract pathogen detection and sperm morphology (mean ± standard deviation).

4 Discussion

Due to the implementation of the two-child policy amendment of China’s Population and Family planning Law, the number of males who want to reproduce offspring has increased significantly (20). In addition, U. urealyticum infection of the genital tract has been confirmed as an important risk factor for male infertility (21). Hence, it is important to determine whether treating male U. urealyticum infections is necessary to improve male reproductive function. Several studies have shown that U. urealyticum infection in the male genital tract negatively affects semen quality (22). This study showed that U. urealyticum infection in the male genital tract significantly affected the pH value, liquefaction time, concentration, and motility of forward-moving sperm in semen samples. These results are consistent with those of most previous studies.

Data collected in this study showed that U. urealyticum infection is common in young males (30.83%). This result was higher than that in most studies (23), which could probably be ascribed to either this study’s detection method or regional differences.

After U. urealyticum infection in the male genital tract, the number, concentration, activity, and survival rate of sperm cells were significantly reduced. Forward sperm and survival rates are the most important parameters for semen quality and directly affect the sperm-egg combination (24), and U. urealyticum infection impacts sperm concentration and forward movement (25). Infection of the reproductive tract leads to male spermatozoa acclimatization and interferes with sperm maturation in convoluted tubules. Furthermore, mixed infections had a more significant effect on routine semen parameters than other pathogens. The number of non-forward motile spermatozoa increases significantly after infection with mixed pathogens (26). The effect of U. urealyticum infection on sperm cells may be due to its ability to adhere to sperm cells and integrate to affect cellular interactions directly. Sperm vitality, motility, morphology, cellular integrity, and molecular structure also deteriorate due to the development of protective immunity against genital infection by the host (population sensitivity to microbial agents).

Compared with semen samples without pathogens, U. urealyticum infection in semen samples significantly increases the rate of sperm malformation (27). When the ratio of normal sperm cells is <4%, it affects the sperm-egg combination and reduces the probability of pregnancy. U. urealyticum infection affects sperm morphology by integrating with sperm cells. It assaults sperm cells in the middle of the head and the area behind the chromosome. The sperm membrane at the adsorption site is damaged or even severely destroyed, making the sperm from streamlined to “bloated,” with abnormal morphology. The tail becomes angled and curled, and some sperm are agglutinated. After U. urealyticum infection, the rate of sperm malformation increases, and abnormal morphology, such as cusps, big heads, double heads, and tailless, increases (28). It can also stimulate the body to produce various inflammatory mediators that damage sperm morphology (29).

Compared with the uninfected group, males with U. urealyticum infection had higher middle segment deformity, round cells, and excessive cytoplasm, which could reduce the ratio of normal sperm and might cause dyspepsia and male infertility (30). Co-incubation of U. urealyticum and sperm led to a significant decrease in the number of motile sperm cells and premature sperm death. U. urealyticum lipopolysaccharide is the main cause of sperm apoptosis, and lipopolysaccharide levels in semen affect sperm quality and function (31). In this study, the normal morphology rate of males infected with U. urealyticum decreased more significantly than that of those infected with other pathogens and the normal volunteers. Therefore, male genital tract infection was closely related to male infertility (32). However, the number of other pathogenic specimens identified was small and should be expanded for further studies.

This study observed that male genital tract infection with U. urealyticum is significantly associated with conventional semen parameters (including morphology). The detection and treatment of U. urealyticum are recommended for males with infertility to improve their semen quality.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.

Ethics statement

Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author contributions

Each author contributed to the search process. The experiments were conceived and designed by FX, FJ, DZ. Carry out experiments: FX, FJ, DZ. HM. Analysis data: FX. Compilation manual: FJ. The manual has been strictly revised, and the final version has been completed/corrected: FX, FJ, HM. All authors contributed to the article and approved the submitted version.

Funding

This study was sponsored by a project of Loan to Supplement (J2018Y03) from the Bureau of Science and Technology of Hefei (China).

Acknowledgments

The authors are grateful to Dr. Yao Chen for her help with the preparation of figures in this paper. We would like to thank the reviewers for their helpful remarks. We thank the associate editor and the reviewers for their useful feedback that improved this paper.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

U. urealyticum, Ureaplasma urealyticum.

References

1. Al-Sweih NA, Al-Fadli AH, Omu AE, Rotimi VO. Prevalence of chlamydia trachomatis, mycoplasma hominis, mycoplasma genitalium, and ureaplasma urealyticum infections and seminal quality in infertile and fertile men in Kuwait. J Androl (2011) 33(6):1323–9. doi: 10.2164/jandrol.111.013821

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Beeton ML, Payne MS, Jones L. The role of ureaplasma spp. in the development of nongonococcal urethritis and infertility among men. Clin Microbiol Rev (2019) 32(4):e00137-18. doi: 10.1128/CMR.00137-18

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Gao E-S, Wu J-Q, Liang C-L, Chen X-K. 501: The relationship between ureaplasma urealyticum infection in the genital tract and semen quality. Am J Epidemiol (2005) 161(Supplement_1):S126–6. doi: 10.1093/aje/161.supplement_1.s126

CrossRef Full Text | Google Scholar

4. Gdoura R, Kchaou W, Chaari C, Znazen A, Keskes L, Rebai T, et al. Ureaplasma urealyticum, ureaplasma parvum, mycoplasma hominis and mycoplasma genitalium infections and semen quality of infertile men. BMC Infect Dis (2007) 7(1):129. doi: 10.1186/1471-2334-7-129

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Huang C, Zhu HL, Xu KR, Wang SY, Fan LQ, Zhu WB. Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta-analysis. Andrology (2015) 3(5):809–16. doi: 10.1111/andr.12078

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Lafuente R, García-Blàquez N, Jacquemin B, Checa MA. Outdoor air pollution and sperm quality. Fertil Steril (2016) 106(4):880–96. doi: 10.1016/j.fertnstert.2016.08.022

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Le MT, Nguyen TLN, Le DD, Ngo TVQ, Nguyen ATC, Nguyen BH, et al. Is genital tract infection related to tubal diseases in infertile Vietnamese women? J Infect Develop Countries (2019) 13(10):906–13. doi: 10.3855/jidc.11632

CrossRef Full Text | Google Scholar

8. Lee JS, Kim KT, Lee HS, Yang KM, Seo JT, Choe JH. Concordance of ureaplasma urealyticum and mycoplasma hominis in infertile couples: Impact on semen parameters. Urology (2013) 81(6):1219–24. doi: 10.1016/j.urology.2013.02.044

PubMed Abstract | CrossRef Full Text | Google Scholar

9. McGill JJ, Baker K, Starks C, Barazani Y, Sabanegh E. The effects of pyospermia and ureaplasma urealyticum culture positivity on semen quality in subfertile men. Fertil Steril (2013) 100(3):S216. doi: 10.1016/j.fertnstert.2013.07.1302

CrossRef Full Text | Google Scholar

10. Moridi K, Hemmaty M, Azimian A, Fallah MH, Khaneghahi Abyaneh H, Ghazvini K. Epidemiology of genital infections caused by mycoplasma hominis, m. genitalium and ureaplasma urealyticum in iran; a systematic review and meta-analysis study (2000–2019). BMC Public Health (2020) 20(1):1020. doi: 10.1186/s12889-020-08962-5

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Zinzendorf NY, Kouassi-Agbessi BT, Lathro JS, Don C, Kouadio L, Louko YG. Ureaplasma urealyticum or mycoplasma hominis infections and semen quality of infertile men in Abidjan. J Reprod Contraception (2008) 19(2):65–72. doi: 10.1016/s1001-7844(08)60008-5

CrossRef Full Text | Google Scholar

12. Ozarda Y, Ichihara K, Barth JH, Klee G. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. Clin Chem Lab Med (2013) 51(5):1027. doi: 10.1515/cclm-2013-0249

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Peerayeh SN, Yazdi RS, Zeighami H, Razeghi M. Ureaplasma urealyticum in semen of men with varicocele. Lab Med (2008) 39(4):215–7. doi: 10.1309/k4nvb47rgfexa9bm

CrossRef Full Text | Google Scholar

14. Riley DE, Samadpour M, Krieger JN. Detection of variable DNA repeats in diverse eukaryotic microorganisms by a single set of polymerase chain reaction primers. J Clin Microbiol (1991) 29(12):2746–51. doi: 10.1128/jcm.29.12.2746-2751.1991

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Wang Y, Han XD, Hou YY, Chen JX. Ureaplasma urealyticuminfection related to seminal plasma immunosuppressive factors, semen ph and liquefaction duration. Arch Androl (2005) 51(4):267–70. doi: 10.1080/014850190923413

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Wang Y, Liang C-L, Wu J-Q, Xu C, Qin S-X, Gao E-S. Do ureaplasma urealyticum infections in the genital tract affect semen quality? Asian J Androl (2006) 8(5):562–8. doi: 10.1111/j.1745-7262.2006.00190.x

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Wang Y, Wu Z-W, Zhang L-F, Wu X-K, Yi L, Han X-D. Effects of ureaplasma urealyticum infection on the male reproductive system in experimental rats. Andrologia (2010) 42(5):297–301. doi: 10.1111/j.1439-0272.2009.00993.x

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Yoshida T, Maeda S-I, Deguchi T, Ishiko H. Phylogeny-based rapid identification of mycoplasmas and ureaplasmas from urethritis patients. J Clin Microbiol (2002) 40(1):105–10. doi: 10.1128/jcm.40.1.105-110.2002

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Zhang Q-F, Zhang Y-J, Wang S, Wei Y, Li F, Feng K-J. The effect of screening and treatment of ureaplasma urealyticum infection on semen parameters in asymptomatic leukocytospermia: a case–control study. BMC Urol (2020) 20(1):165. doi: 10.1186/s12894-020-00742-y

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Zhou YH, Ma HX, Shi XX, Liu Y. Ureaplasma spp. in male infertility and its relationship with semen quality and seminal plasma components. J Microbiol Immunol Infect (2018) 51(6):778–83. doi: 10.1016/j.jmii.2016.09.004

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Zhu X, Li M, Cao H, Yang X, Zhang C. Epidemiology of ureaplasma urealyticum and mycoplasma hominis in the semen of male outpatients with reproductive disorders. Exp Ther Med (2016) 12(2):1165–70. doi: 10.3892/etm.2016.3409

PubMed Abstract | CrossRef Full Text | Google Scholar

22. EzzEl-Din AM, Gaber HD, Kamal DT. Chlamydia trachomatis infection: its relation to semen parameters and sperm DNA integrity. Egypt J Immunol (2021) 28:290–8. doi: 10.55133/eji.280430

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Jaworek H, Koudelakova V, Oborna I, Zborilova B, Brezinova J, Ruzickova D, et al. Impact of human papillomavirus infection on semen parameters and reproductive outcomes. Reprod Biol Endocrinol (2021) 19:156. doi: 10.1186/s12958-021-00840-y

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Liu KS, Mao XD, Pan F, An RF. Effect and mechanisms of reproductive tract infection on oxidative stress parameters, sperm DNA fragmentation, and semen quality in infertile males. Reprod Biol Endocrinol (2021) 19:97. doi: 10.1186/s12958-021-00781-6

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Perez-Soto E, Fernandez-Martinez E, Oros-Pantoja R, Medel-Flores O, Miranda-Covarrubias JC, Sanchez-Monroy V. Proinflammatory and oxidative stress states induced by human papillomavirus and chlamydia trachomatis coinfection affect sperm quality in asymptomatic infertile men. Med (Kaunas) (2021) 57(9):862. doi: 10.3390/medicina57090862

CrossRef Full Text | Google Scholar

26. Tam Le M, Nguyen Nguyen D, Bach Nguyen H, Quynh Tram Ngo V, Quoc Huy Nguyen V. Ureaplasma urealyticum and mycoplasma genitalium detection and sperm quality: A cross-sectional study in Vietnam. Int J Reprod BioMed (2021) 20:185–94. doi: 10.18502/ijrm.v20i3.10710

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Wang Z, Liu W, Zhang M, Wang M, Wu H, Lu M. Effect of hepatitis b virus infection on sperm quality and outcomes of assisted reproductive techniques in infertile males. Front Med (Lausanne) (2021) 8:744350. doi: 10.3389/fmed.2021.744350

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Bai S, Li Y, Hu MH, Wu L, Shui LJ, Wang XH, et al. Association of sexually transmitted infection with semen quality in men from couples with primary and secondary infertility. Asian J Androl (2022) 24:317–22. doi: 10.4103/aja202164

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Hulse L, Palmieri C, Beagley KW, Larkin R, Keeley T, Gosalvez J, et al. Investigation of pathology associated with chlamydia pecorum infection in the male reproductive tract, and the effect on spermatogenesis and semen quality in the koala (Phascolarctos cinereus). Theriogenology (2022) 180:30–9. doi: 10.1016/j.theriogenology.2021.12.011

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Liu H, Song X, Huang M, Zhan H, Wang S, Zhu S, et al. Ureaplasma urealyticum induces polymorphonuclear elastase to change semen properties and reduce sperm motility: a prospective observational study. J Int Med Res (2022) 50:3000605221106410. doi: 10.1177/03000605221106410

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Liu H, Yang K, He L, Zhu S, Pang T, Zhu Z, et al. Risk prediction of ureaplasma urealyticum affecting sperm quality based on mathematical model and cross-sectional study. Comput Math Methods Med (2022) 2022:2498306. doi: 10.1155/2022/2498306

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Makarounis K, Leventopoulos M, Georgoulias G, Nikolopoulos D, Zeginiadou T, Xountasi M, et al. Detection of chlamydia trachomatis inside spermatozoa using flow cytometry: Effects of antibiotic treatment (before and after) on sperm count parameters. J Microbiol Methods (2022) 203:106604. doi: 10.1016/j.mimet.2022.106604

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Ureaplasma urealyticum, semen quality, sperm morphology, male genitourinary infection, infertile men

Citation: Xianchun F, Jun F, Zhijun D and Mingyun H (2023) Effects of Ureaplasma urealyticum infection on semen quality and sperm morphology. Front. Endocrinol. 14:1113130. doi: 10.3389/fendo.2023.1113130

Received: 01 December 2022; Accepted: 23 February 2023;
Published: 06 March 2023.

Edited by:

John Even Schjenken, The University of Newcastle, Australia

Reviewed by:

Marianna Santonastaso, Università degli Studi della Campania “Luigi Vanvitelli”, Italy
Roland Eghoghosoa Akhigbe, Ladoke Akintola University of Technology, Nigeria

Copyright © 2023 Xianchun, Jun, Zhijun and Mingyun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hong Mingyun, 2006mingyun@sina.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.